Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 7 publications
Pharmacological inhibition of S-nitrosoglutathione reductase improves endothelial vasodilatory function in rats in vivo.
Journal: Journal of applied physiology (Bethesda, Md. : 1985)
Published: January 26, 2013
Pharmacologic inhibition of S-nitrosoglutathione reductase protects against experimental asthma in BALB/c mice through attenuation of both bronchoconstriction and inflammation.
Journal: BMC pulmonary medicine
Published: November 01, 2012
ADH IB expression, but not ADH III, is decreased in human lung cancer.
Journal: PloS one
Published: October 23, 2012
Mechanism of inhibition for N6022, a first-in-class drug targeting S-nitrosoglutathione reductase.
Journal: Biochemistry
Published: February 17, 2012
A nonclinical safety and pharmacokinetic evaluation of N6022: a first-in-class S-nitrosoglutathione reductase inhibitor for the treatment of asthma.
Journal: Regulatory toxicology and pharmacology : RTP
Published: October 20, 2011
Structure-activity relationship of pyrrole based S-nitrosoglutathione reductase inhibitors: carboxamide modification.
Journal: Bioorganic & medicinal chemistry letters
Published: October 06, 2011
Showing 1-7 of 7
Last Updated: 09/26/2026